This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Allowing Ballad Health COPA to expire poses anticompetitive risks, US FTC tells Tennessee

( April 2, 2026, 14:56 GMT | Official Statement) -- MLex Summary: The US Federal Trade Commission warned Tennessee legislators of the potential consequences from proposed legislation that would terminate a certificate of public advantage that provides state regulatory oversight for Ballad Health. The bills would allow the Ballad Health COPA to expire in June 2028, ending the Tennessee Department of Health’s supervision over Ballad Health’s quality of healthcare services, availability and access to care, as well as population health initiatives. The FTC said that doing so poses potential anticompetitive consequences to patients, which include higher healthcare costs and lower quality of care.Statement follows in full. Also see attached file. ...

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login

Documents

Related Sections